- Record: found
- Abstract: found
- Article: not found
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team.
O Pontesilli
1 ,
E C Guerra ,
A Ammassari ,
C Tomino ,
M Carlesimo ,
A Antinori ,
E Tamburrini ,
A Prozzo ,
A C Seeber ,
S Vella ,
L Ortona ,
F Aiuti
Mar 26 1998
Read this article at
ScienceOpenPubMed
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To alter the natural course of HIV-1 infection by inducing or potentiating immune responses to HIV-1 envelope glycoprotein.